| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.098 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |